Upload
Featured Recent Articles Topics Login Upload

Search Results for 'oral hiv'

oral hiv published presentations and documents on DocSlides.

Module 5: MONITORING, FOLLOW-UP, AND ADHERENCE SUPPORT FOR AGYW
Module 5: MONITORING, FOLLOW-UP, AND ADHERENCE SUPPORT FOR AGYW
by calandra-battersby
Module 5: MONITORING, FOLLOW-UP, AND ADHERENCE S...
“On Demand” Oral PrEP: Lessons Learned from Macaque Models
“On Demand” Oral PrEP: Lessons Learned from Macaque Models
by giovanna-bartolotta
“On Demand” Oral PrEP: Lessons Learned from M...
International Journal of Medicine and Medical Sciences Vol 33 pp
International Journal of Medicine and Medical Sciences Vol 33 pp
by williams
84 Int. J. Med. Med. Sci. Figure 1. Pr...
Immune surveillance and viral shedding
Immune surveillance and viral shedding
by garcia
81 4 Subclinical reactivation of VZV has been less...
Dapivirine Ring Introduction Framework and Key Insights
Dapivirine Ring Introduction Framework and Key Insights
by valerie
PLAN. 4 . RING . TOOLKIT. PROMISE. Preparing for ...
Jeanne Marrazzo, MD, MPH
Jeanne Marrazzo, MD, MPH
by rose
Professor of Medicine. University of Washington. S...
Cabotegravir plus Rilpivirine
Cabotegravir plus Rilpivirine
by jaxson809
Extended Release Injectable Suspension. Last Updat...
Malawi Path to Scale study and programmatic considerations that are guiding the country program
Malawi Path to Scale study and programmatic considerations that are guiding the country program
by jadiel
Welcome to the era of PrEP choice. Rose Nyirenda, ...
Orofacial Viral Infections
Orofacial Viral Infections
by mila-milly
K berry. . Affect the skin or mucous membranes of...
What’s Next – and When:
What’s Next – and When:
by sherrill-nordquist
An Update on Injectable . P. revention. Alex R Ri...
Weekly Oral MK-8591 Protects Male Rhesus Macaques against R
Weekly Oral MK-8591 Protects Male Rhesus Macaques against R
by cheryl-pisano
Intrarectal. Challenge with SHIV109CP3. Martin M...
Highlights for clinical
Highlights for clinical
by pasty-toler
. practice. HIV. International Congress of Drug ...
Long Acting ART for Treatment and
Long Acting ART for Treatment and
by tatyana-admore
PrEP. Anton Pozniak . MD FRCP. Consultant Physici...
SEXUALLY TRANSMITTED DISEASES
SEXUALLY TRANSMITTED DISEASES
by alida-meadow
Lynne D. Feldman, MD, MPH – District Health Dir...
ADOLESCENT PrEP STUDIES
ADOLESCENT PrEP STUDIES
by min-jolicoeur
. . Shorai. . Mukaka. , . MBchB. ...
Characteristics and Oral
Characteristics and Oral
by lois-ondreau
PrEP. Adherence in the TDF2 Open-Label Extension...
Long Acting Injectable Agents for HIV Prevention
Long Acting Injectable Agents for HIV Prevention
by giovanna-bartolotta
Nyaradzo M Mgodi (. MBChB. , . MMed. ). On behalf...
PrEP Training for
PrEP Training for
by tatyana-admore
Providers in Clinical Settings. 2. Welcome!. Plea...
Yale College Student Investment Group
Yale College Student Investment Group
by lois-ondreau
Gilead Sciences Inc. (GILD). Presented by: . Sudh...
ART as prevention: PEP &
ART as prevention: PEP &
by phoebe-click
PrEP. Dr. Laura Waters. HIV/GU Medicine. Brighto...
P r EP introduction
P r EP introduction
by olivia-moreira
P r EP introduction for Adolescent Girls and Yo...
SEXUALLY TRANSMITTED DISEASES
SEXUALLY TRANSMITTED DISEASES
by celsa-spraggs
Lynne D. Feldman, MD, MPH – District Health Dir...
1 Yale University School of Medicine, New Haven, United States,
1 Yale University School of Medicine, New Haven, United States,
by thomas
2. Icahn School of Medicine at Mount Sinai, New Yo...
Subgroup Efficacy Analyses of
Subgroup Efficacy Analyses of
by eddey
Long-Acting Subcutaneous Lenacapavir in . Heavily ...
Immunological diseases Dr.
Immunological diseases Dr.
by lucinda
Husham. . Aldaoseri. 11-Oct. 2023. Innate immunit...
Situation Analysis for the Introduction of the PrEP Ring
Situation Analysis for the Introduction of the PrEP Ring
by jovita
Overview and Instructions. PLAN. 4 . RING . TOOLK...
Investigational Antiretroviral Agents:
Investigational Antiretroviral Agents:
by ava
Transforming the Care of People with HIV . Rajesh ...
CROI 2019 Scientific summary of the major clinical studies presented at CROI 2019
CROI 2019 Scientific summary of the major clinical studies presented at CROI 2019
by blanko
Résumé scientifique des principales études clin...
This resource summarizes the guidelines for prevention and treatment o
This resource summarizes the guidelines for prevention and treatment o
by quinn
Preferred OI Primary ProphylaxisNOTE: See AP See s...
Coinfections: Old and new
Coinfections: Old and new
by ceila
Re-emerging . h. epatitis A. Philip Yi-Chun Lo, MD...
What’s New & Next in
What’s New & Next in
by badra
HIV Prevention . Mitchell Warren. July 2021. Outli...
CUTANEOUS MANIFESTATIONS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
CUTANEOUS MANIFESTATIONS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
by kylie
BY. DR. JAHNABI. MODERATOR. DR. BHASKAR GUPTA, PR...
Lauren Horton
Lauren Horton
by stefany-barnette
Brittney Ho. Hairy Leukoplakia. . Results . fro...
State
State
by pasty-toler
of the evidence from oral and topical . PrEP. ef...
First study of repeat dose
First study of repeat dose
by pamella-moone
co-administration of GSK1265744 . and TMC278 long...
Risk of HIV infection attributable to oral sex amon g
Risk of HIV infection attributable to oral sex amon g
by pasty-toler
Sponsorship This work was supported by a grant fr...
Page Oral Sex and HIV Risk
Page Oral Sex and HIV Risk
by debby-jeon
800CDCINFO2324636 In English en Espa57585ol 24 Hou...
Switch to INSTI + NNRTI
Switch to INSTI + NNRTI
by giovanna-bartolotta
Switch to DTG + RPV. SWORD. . Study. Switch to C...
Planning and Managing a Dental Continuous quality Improvement project
Planning and Managing a Dental Continuous quality Improvement project
by karlyn-bohler
Liza Kasmara, Ed.M. . Kareem Merrick, DDS . Mouss...
ARV Procurement and Value For Money
ARV Procurement and Value For Money
by marina-yarberry
Cameroon Perspectives . IAS, Paris 23 July, . 201...